Pharma R&D Efficiency: Big, Mid And Japan Pharma Peer Sets

Datamonitor Healthcare evaluated R&D efficiency in terms of new product launch success rates for three peer sets: Big Pharma, Mid Pharma and Japan Pharma.

More from Archive

More from In Vivo